Navigation Links
SGX Pharmaceuticals Announces Financial Results for the Three and Nine Months Ended September 30, 2007
Date:11/13/2007

3 30,997 35,590

General and

administrative 2,050 1,864 6,419 7,420

Total operating expenses 12,515 10,447 37,416 43,010

Loss from operations (4,929) (3,680) (10,356) (23,667)

Interest income (expense),

net 156 282 472 500

Net loss (4,773) (3,398) (9,884) (23,167)

Accretion to redemption

value of redeemable

convertible preferred stock - - - (49)

Net loss attributable to

common stockholders $(4,773) $(3,398) $(9,884) $(23,216)

Basic and diluted net loss

per share attributable to

common stockholders $(0.31) $(0.23) $(0.65) $(1.74)

Shares used to compute

basic and diluted net

loss per share

attributable to

common stockholders 15,392 15,048 15,318 13,323

Three Months Ended Three Months Ended

September 30, 2007 (1) September 30, 2006 (1)

Stock-based Reported Stock-based Reported

compensation GAAP compensation GAAP

non-GAAP expense results non-GAAP expense results

Net loss

attributable to

common

stockholders $(4,084) $(689) $(4,773) $(2,462) $(936) $(3,398)

Basic and

diluted net

loss per share

attributable

to common

stockholders $(0.27) $(0.04) $(0.31) $(0.16) $(0.06) $(0.23)

Research and

development

expenses $10,105 $360 $10,465 $8,222 $361 $8,583

General and

administrative

expenses $1,721 $329 $2,050 $1,289 $575 $1,864

Nine
'/>"/>

SOURCE SGX Pharmaceuticals
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
2. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
3. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
4. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
5. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
6. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
8. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
9. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
10. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
11. Class Settlement Could Result in Considerable Savings for Certain Consumers of Prescription Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... Jacksonville, Fla. (PRWEB) May 05, 2015 ... from the Commission on Cancer (CoC) of the American ... a cancer program must meet more than 30 Commission ... years through a survey process, and maintain levels of ... , When patients choose to seek care locally ...
(Date:5/5/2015)... Nutritional science and medical research has enabled ... health conditions and illnesses linked to carrying excess weight. ... eating methods to rid the body of dangerous toxins, ... fast and processed foods. Patients find the company’s ... report feeling better and losing excess fat within days. ...
(Date:5/5/2015)... 05, 2015 In a April 25, 2015, ... Herald-Times , the Missouri State Highway Patrol (MSHP) announced that ... or use for the second year in a row. ... FBI, reported 1,469 incidents in 2014 alone, around 15% of ... 2% of the US Population calls Indiana home, according to ...
(Date:5/5/2015)... Information Innovators Inc. (“Triple-i”), ... government, today announced its acquisition of Creative ... exclusively to federal government customers through its highly ... health services, and program management support. The company ... a Third Party Assessment Organization (3PAO) for cloud ...
(Date:5/5/2015)... Freeport, Grand Bahama (PRWEB) May 05, 2015 ... published its Orthopedic Lifestyle Report today. The study was ... orthopedic conditions such as osteoarthritis and sports-related ... chronic pain and stiffness was the most prevalent symptom ... reduced functionality such as walking, standing and bending over. ...
Breaking Medicine News(10 mins):Health News:Baptist Medical Center Jacksonville Receives National Cancer Reaccreditation 2Health News:Baptist Medical Center Jacksonville Receives National Cancer Reaccreditation 3Health News:Baptist Medical Center Jacksonville Receives National Cancer Reaccreditation 4Health News:Diet Doc Introduces Diet Plans that Teach Patients how to Eat Clean by Getting Back to Basics and Exchanging Processed Foods for Clean, Nutritious Foods 2Health News:Diet Doc Introduces Diet Plans that Teach Patients how to Eat Clean by Getting Back to Basics and Exchanging Processed Foods for Clean, Nutritious Foods 3Health News:A Forever Recovery Releases New Information on the Epidemic Rise Of Methamphetamine Abuse in Midwest America 2Health News:Information Innovators Inc. (Triple-i) Acquires Leading Cyber Security and Health-Focused Solutions Company, Creative Computing Solutions, Inc. 2Health News:Information Innovators Inc. (Triple-i) Acquires Leading Cyber Security and Health-Focused Solutions Company, Creative Computing Solutions, Inc. 3Health News:Information Innovators Inc. (Triple-i) Acquires Leading Cyber Security and Health-Focused Solutions Company, Creative Computing Solutions, Inc. 4Health News:Okyanos Study Finds Orthopedic Patients Plagued with Pain 2Health News:Okyanos Study Finds Orthopedic Patients Plagued with Pain 3
... Giving shot 2 weeks earlier reduces the time babies ... 3 (HealthDay News) -- Giving infants a routine pertussis ... prevent at least 1,236 cases of pertussis, 898 hospitalizations ... a new study finds. , Researchers at Wake Forest ...
... the top 100, EL SEGUNDO, Calif., Nov. ... care services for those diagnosed with chronic kidney,failure ... 100 of Modern Healthcare,s,Best Places to Work in ... only nationwide healthcare services company on the list., ...
... Inc. and to Continue,Trading on NASDAQ under ... Cornerstone BioPharma,Holdings, Inc., a specialty pharmaceutical company ... respiratory disorders,today announced the completion of its ... biopharmaceutical company focused on,developing and commercializing innovative ...
... 3 Avineuro Pharmaceuticals, Inc.,announced today the completion ... for treatment of Alzheimer,s disease. These studies,demonstrate that ... it has a,favorable pharmacokinetic profile. Based on these ... AVN-101 into clinical,trials in Q1 2009. Results of ...
... adoption of daily home therapy continues to grow; ... LAWRENCE, Mass., Nov. 3 NxStage Medical, Inc.,(Nasdaq: ... dialysis products,today announced that 3,000 end-stage renal disease ... its NxStage(R) System One(TM), the,first truly portable home ...
... a leading provider of laser vision correction services under ... team will present at the Rodman & Renshaw 10th ... a.m. Eastern time. The,conference is being held at The ... A live and archived webcast of the event will ...
Cached Medicine News:Health News:Earlier Vaccination Could Cut Whooping Cough Deaths 2Health News:Modern Healthcare Names DaVita One of the Best Places to Work 2Health News:Cornerstone BioPharma Announces Completion of Merger with Critical Therapeutics 2Health News:Cornerstone BioPharma Announces Completion of Merger with Critical Therapeutics 3Health News:Cornerstone BioPharma Announces Completion of Merger with Critical Therapeutics 4Health News:Cornerstone BioPharma Announces Completion of Merger with Critical Therapeutics 5Health News:NxStage(R) Achieves Milestone with 3,000 End-Stage Renal Disease Patients Receiving Daily Home Hemodialysis Therapy 2Health News:NxStage(R) Achieves Milestone with 3,000 End-Stage Renal Disease Patients Receiving Daily Home Hemodialysis Therapy 3Health News:NxStage(R) Achieves Milestone with 3,000 End-Stage Renal Disease Patients Receiving Daily Home Hemodialysis Therapy 4
(Date:5/5/2015)... 2015 Research and Markets ( ... "Electro Surgical Market" report to their ... expected to achieve a CAGR of 7% for ... benefits for patients as well as surgeons such ... visible marks, bleeding control and improved accuracy are ...
(Date:5/5/2015)... -- IQPC,s 19 th Software Design for Medical Devices ... Summit Mr. Phani Bidarahalli , GM & Head of ... expert speaker faculty including senior executive from GE Healthcare, Philips ... The Hotel Kabuki in San Francisco . ... the event website, which can be accessed by visiting ...
(Date:5/5/2015)... Lymphatic pump treatment (LPT) shows promise in managing pneumonia ... study published in The Journal of the American ... on infected rats three times a day followed by ... pneumonia. After 96 hours, over 60 percent of the ... of rats who received levofloxacin alone. Commonly ...
Breaking Medicine Technology:Global Electro Surgical Market 2015 2Phani Bidarahalli from Wipro to chair the upcoming 19th Software Design for Medical Devices Summit in San Francisco 2Lymphatic Pump Treatment Enhances Antibiotic Effectiveness for Treating Pneumonia 2
For use in cleaning soft contact lenses. Sensitive Eyes daily cleaner loosens and removes accumulations of film, deposits, and debris from soft contact lenses. Use with heat, chemical, and hydrogen p...
Refresh Contacts provides moisturizing relief from dryness and irritation associated with lens wear....
Specially formulated to lubricate and moisten lenses to help relieve irritation and dryness....
... Renu Multiplus preservative free ... and moisturize your eyes while ... The gentle preservative free formula ... may be sensitive to preservatives ...
Medicine Products: